These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2373993)

  • 1. Isolation and characterization of a complement-activating lipid extracted from human atherosclerotic lesions.
    Seifert PS; Hugo F; Tranum-Jensen J; Zâhringer U; Muhly M; Bhakdi S
    J Exp Med; 1990 Aug; 172(2):547-57. PubMed ID: 2373993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prelesional complement activation in experimental atherosclerosis. Terminal C5b-9 complement deposition coincides with cholesterol accumulation in the aortic intima of hypercholesterolemic rabbits.
    Seifert PS; Hugo F; Hansson GK; Bhakdi S
    Lab Invest; 1989 Jun; 60(6):747-54. PubMed ID: 2659887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of complement C3 activation products in human atherosclerotic lesions.
    Seifert PS; Messner M; Roth I; Bhakdi S
    Atherosclerosis; 1991 Nov; 91(1-2):155-62. PubMed ID: 1811551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unesterified cholesterol-rich lipid particles in atherosclerotic lesions of human and rabbit aortas.
    Chao FF; Amende LM; Blanchette-Mackie EJ; Skarlatos SI; Gamble W; Resau JH; Mergner WT; Kruth HS
    Am J Pathol; 1988 Apr; 131(1):73-83. PubMed ID: 3354646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement activation by oxidatively modified low-density lipoproteins.
    Wieland E; Dorweiler B; Bonitz U; Lieser S; Walev I; Bhakdi S
    Eur J Clin Invest; 1999 Oct; 29(10):835-41. PubMed ID: 10583425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The complement system in atherosclerosis.
    Seifert PS; Kazatchkine MD
    Atherosclerosis; 1988 Oct; 73(2-3):91-104. PubMed ID: 3056433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of two unique cholesterol-rich lipid particles isolated from human atherosclerotic lesions.
    Chao FF; Blanchette-Mackie EJ; Chen YJ; Dickens BF; Berlin E; Amende LM; Skarlatos SI; Gamble W; Resau JH; Mergner WT
    Am J Pathol; 1990 Jan; 136(1):169-79. PubMed ID: 2297045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible protective role for C-reactive protein in atherogenesis: complement activation by modified lipoproteins halts before detrimental terminal sequence.
    Bhakdi S; Torzewski M; Paprotka K; Schmitt S; Barsoom H; Suriyaphol P; Han SR; Lackner KJ; Husmann M
    Circulation; 2004 Apr; 109(15):1870-6. PubMed ID: 15037531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement activation and atherosclerosis.
    Niculescu F; Rus H
    Mol Immunol; 1999; 36(13-14):949-55. PubMed ID: 10698349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoelectron-microscopic localization of the terminal C5b-9 complement complex in human atherosclerotic fibrous plaque.
    Rus HG; Niculescu F; Constantinescu E; Cristea A; Vlaicu R
    Atherosclerosis; 1986 Jul; 61(1):35-42. PubMed ID: 3524587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative evaluation of the terminal C5b-9 complement complex by ELISA in human atherosclerotic arteries.
    Niculescu F; Hugo F; Rus HG; Vlaicu R; Bhakdi S
    Clin Exp Immunol; 1987 Aug; 69(2):477-83. PubMed ID: 3652536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the pathogenesis of atherosclerosis: enzymatic transformation of human low density lipoprotein to an atherogenic moiety.
    Bhakdi S; Dorweiler B; Kirchmann R; Torzewski J; Weise E; Tranum-Jensen J; Walev I; Wieland E
    J Exp Med; 1995 Dec; 182(6):1959-71. PubMed ID: 7500042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of the human terminal complement pathway in atherosclerosis.
    Niculescu F; Rus HG; Vlaicu R
    Clin Immunol Immunopathol; 1987 Nov; 45(2):147-55. PubMed ID: 2444373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement receptors in atherosclerotic lesions.
    Saito E; Fujioka T; Kanno H; Hata E; Ueno T; Matsumoto T; Takahashi Y; Tochihara T; Yasugi T
    Artery; 1992; 19(1):47-62. PubMed ID: 1531410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunology of atherosclerosis. Demonstration of heat shock protein 60 expression and T lymphocytes bearing alpha/beta or gamma/delta receptor in human atherosclerotic lesions.
    Kleindienst R; Xu Q; Willeit J; Waldenberger FR; Weimann S; Wick G
    Am J Pathol; 1993 Jun; 142(6):1927-37. PubMed ID: 8099471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-localization of terminal C5b-9 complement complexes and macrophages in human atherosclerotic arterial walls.
    Rus HG; Niculescu F; Vlaicu R
    Immunol Lett; 1988 Sep; 19(1):27-32. PubMed ID: 3192278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between macrophages and C5b-9 complement complexes in human atherosclerosis.
    Rus HG; Niculescu F; Vlaicu R
    Clin Immunol Immunopathol; 1988 Sep; 48(3):307-16. PubMed ID: 3042211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of atheroma liposomes and malondialdehyde-modified low-density lipoproteins in complement activation.
    Sorace JM; Rollins S; Aniagolu JU; Mergner WJ; Cole K; Swartz GM; Green SJ
    Pathobiology; 1996; 64(2):73-8. PubMed ID: 8888272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative inefficiency of terminal complement activation.
    Bhakdi S; Fassbender W; Hugo F; Carreno MP; Berstecher C; Malasit P; Kazatchkine MD
    J Immunol; 1988 Nov; 141(9):3117-22. PubMed ID: 3262681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Localization of the terminal C5b-9 complement complex in the human aortic atherosclerotic wall.
    Niculescu F; Rus H; Cristea A; Vlaicu R
    Immunol Lett; 1985; 10(2):109-14. PubMed ID: 3897036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.